PATH | VRL
Menu

Find resources

Total results with these characteristics: 1849

Page 91 of 93
VIEW-hub – Vaccine Information and Epidemiology Window

This web page provides a link to the most recent VIEW-hub Report, as well as an archive of earlier reports. This quarterly report provides data and figures on the introduction status of Haemophilus influenzae type b, pneumococcal conjugate, …

Author: International Vaccine Access Center

Vigilancia Epidemiológica de Diarreas Causadas por Rotavirus

This Spanish-language document provides information on rotavirus disease and vaccines, including epidemiology and prevention and treatment of the disease.

Author: Pan American Health Organization

Publication date: 2007

VillageReach

VillageReach is an entrepreneurial, nonprofit organization that assures access to lifesaving immunizations for families in low-income countries with the greatest need.

Author: VillageReach

Viral and Host Factors in Human Respiratory Syncytial Virus Pathogenesis

The authors of this article, published in the Journal of Virology, discuss the contributions of viral versus various host factors to respiratory syncytial virus (RSV) pathogenesis. The authors conclude that a better understanding of the viral and …

Author: Collins PL, Graham BS

Publication date: 2008

VoICE, the Value of Immunization Compendium of Evidence

This interactive online database provides information on the broad benefits and value of immunization and costs of vaccine-preventable disease. The Value of Immunization Compendium of Evidence (VoICE) tool contains more than 100 policy-focused …

Author: International Vaccine Access Center

Voices for Vaccines

This organization advocates for sound vaccine policies and practices. It aims to provide clear, accessible, science-based information about vaccines and vaccine-preventable diseases. This organizational website provides information about the …

Author: Voices for Vaccines

Weekly Epidemiological Record

Similar to the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report, these World Health Organization archives contain global disease surveillance information.

Author: World Health Organization

What Do the Next 100 Years Hold for Pneumococcal Vaccination?

This editorial article, published in Expert Review of Vaccines, provides a brief historical overview of vaccination against pneumococcal disease and offers a perspective on the future of pneumococcal vaccines. The authors describe the …

Author: Rijkers GT, van Mens SP, van Velzen-Blad H

Publication date: 2010

What Information Do You Need to Drive Your Immunization Program?

This three-part banner illustrates how better access to information can help improve the performance of vaccination programs.

Author: PATH, World Health Organization

Publication date: 2013

What Vaccine Product Attributes Do Immunization Program Stakeholders Value? Results From Interviews in Six Low- and Middle-Income Countries

This article, published in Vaccine, reports the results of a study that aimed to capture the opinions of stakeholders working in immunization programs in low- and middle-income countries in order to understand how vaccine products could be improved …

Author: Kristensen DD, Bartholomew K, Villadiego S, Lorenson K

Publication date: 2016

What Would Happen if We Stopped Vaccinations?

This web page provides a summary of disease-related consequences of stopping immunizations. Vaccination programs have eliminated or significantly reduced many vaccine-preventable diseases in the United States and elsewhere. However, these diseases …

Author: US Centers for Disease Control and Prevention

Which Pneumococcal Serogroups Cause the Most Invasive Disease: Implications for Conjugate Vaccine Formulation and Use, Part I

Published in the journal Clinical Infectious Diseases, this study analyzed more than 70 recent data sets to compare the serogroups causing invasive pneumococcal disease with those represented in conjugate vaccine formulations. ABSTRACT ONLY. (Learn …

Author: Hausdorff WP, Bryant J, Paradiso P, Siber G

Publication date: 2000

White Paper – Rotavirus: Common, Severe, Devastating, Preventable

This white paper provides a comprehensive source of information on rotavirus disease and vaccines. The 50-page synthesis includes the latest evidence and programmatic information about: rotavirus disease burden; vaccines in global use, nationally …

Author: ROTA Council

Publication date: 2016

WHO Best Practices for Injections and Related Procedures Toolkit

This toolkit covers elements of standard precautions relevant to the transmission of bloodborne pathogens through unsafe injection practices in health-care settings. It aims to help to increase health workers’ awareness of the importance of …

Author: World Health Organization, Safe Injection Global Network

Publication date: 2010

WHO Brighton Collaboration on Maternal Immunization Meeting Report

This report summarizes a consultation meeting held jointly by the World Health Organization's Initiative for Vaccine Research and the Brighton Collaboration in Geneva, Switzerland, from July 24 to 25, 2014 to facilitate harmonization of key events …

Author: World Health Organization

Publication date: 2014

WHO Cervical Cancer Prevention and Control Costing (C4P) Tool User Guide

The World Health Organization has developed a generic costing and planning tool for cervical cancer prevention and control to help program planners and managers generate annual cost projections over a five-year period to scale-up human …

Author: World Health Organization

Publication date: 2012

WHO Consultation on Group B Streptococcus Vaccine Development: Report From a Meeting Held on 27-28 April 2016

This article, published in Vaccine, reports the outcome of a World Health Organization technical consultation that considered development pathways for group B Streptococcus (GBS) vaccines. The meeting discussed numerous topics, including disease …

Author: Kobayashi M, Schrag SJ, Alderson MR, et al.

Publication date: 2016

WHO Consultation on Respiratory Syncytial Virus Vaccine Development Report From a World Health Organization Meeting Held on 23–24 March 2015

This article, published in Vaccine, summarizes a World Health Organization-convened respiratory syncytial virus (RSV) vaccine consultation held on March 23 and 24, 2015 in Geneva, Switzerland, which brought together experts from around the world to …

Author: Modjarrad K, Giersing B, Kaslow DC, Smith PG, Moorthy VS, the WHO RSV Vaccine Consultation Expert Group

Publication date: 2015

WHO Expert Consultation on Serotype Composition of Pneumococcal Conjugate Vaccines for Use in Resource-Poor Developing Countries, 26–27 October 2006, Geneva.

Published in the journal Vaccine, this article reports on a World Health Organization expert consultation to formulate a data-driven approach to determine the minimum or optimal formulation of pneumococcal conjugate vaccines, particularly keeping in …

Author: Cherian T

Publication date: 2007

WHO Global Action Plan to Minimize Poliovirus Facility-Associated Risk After Type-Specific Eradication of Wild Polioviruses and Sequential Cessation of Oral Polio Vaccine Use

This is the third edition of the Global Action Plan for eradicating polio. It includes suggested guidelines for the safe handling and containment of poliovirus infectious and potentially infectious materials, with the goal of reduced risk of …

Author: World Health Organization

Publication date: 2015

Page 91 of 93